# Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years

> **NCT03273946** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 158 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Fluticasone propionate

## Key facts

- **NCT ID:** NCT03273946
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-09
- **Primary completion:** 2018-09-27
- **Final completion:** 2018-09-27
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2019-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03273946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03273946, "Post-marketing Safety Monitoring Program of Fluticasone Propionate (FP) in Chinese Subjects With Asthma Aged 1 to <4 Years". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03273946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*